Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perl

Showing results (101-110 of 3,149) with videos related to

Pageof 315
Sort By:
Blood|November 14, 2024
Approaching a therapeutic inflection point for FLT3-mutated AMLAlexander E Perl
Journal of General Internal Medicine|September 11, 2002
Influenza vaccines: why are we missing high-risk patients?Trish M Perl
Blood|November 19, 2020
MLL-menin and FLT3 inhibitors team up for AMLAlexander E Perl
Best Practice & Research. Clinical Haematology|March 25, 2021
Which novel agents will have a clinically meaningful impact in AML at diagnosis?Alexander E Perl
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1980
Afferent basis of nociception and pain: evidence from the characteristics of sensory receptors and their projections to the spinal dorsal hornE R Perl
Canadian Medical Association Journal|March 19, 2010
Palindromic rheumatismA F PERL
Addictive Behaviors|February 26, 2011
Addicted to discovery: Does the quest for new knowledge hinder practice improvement?Harold I Perl
Progress in Neurobiology|March 23, 2011
Pain mechanisms: a commentary on concepts and issuesEdward R Perl
Advances in Experimental Medicine and Biology|January 1, 1996
Advances in tryptophan analysis in peptides and proteinsI Molnár-Perl
Blood Advances|January 4, 2018
The role of targeted therapy in the management of patients with AMLAlexander E Perl
Pageof 315

Showing results (101-110 of 3,149) with videos related to

Sort By:
Pageof 315
Blood|November 14, 2024
Approaching a therapeutic inflection point for FLT3-mutated AMLAlexander E Perl
Journal of General Internal Medicine|September 11, 2002
Influenza vaccines: why are we missing high-risk patients?Trish M Perl
Blood|November 19, 2020
MLL-menin and FLT3 inhibitors team up for AMLAlexander E Perl
Best Practice & Research. Clinical Haematology|March 25, 2021
Which novel agents will have a clinically meaningful impact in AML at diagnosis?Alexander E Perl
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1980
Afferent basis of nociception and pain: evidence from the characteristics of sensory receptors and their projections to the spinal dorsal hornE R Perl
Canadian Medical Association Journal|March 19, 2010
Palindromic rheumatismA F PERL
Addictive Behaviors|February 26, 2011
Addicted to discovery: Does the quest for new knowledge hinder practice improvement?Harold I Perl
Progress in Neurobiology|March 23, 2011
Pain mechanisms: a commentary on concepts and issuesEdward R Perl
Advances in Experimental Medicine and Biology|January 1, 1996
Advances in tryptophan analysis in peptides and proteinsI Molnár-Perl
Blood Advances|January 4, 2018
The role of targeted therapy in the management of patients with AMLAlexander E Perl
Pageof 315